{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:07:12Z","timestamp":1794244032183,"version":"4.9.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA197363"],"award-info":[{"award-number":["R01CA197363"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The UCSF ImmunoX HuMu CoProject funding (internal to UCSF) was obtained by MFK."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mouse models are frequently used to develop treatments for human cancer. However, the degree to which their tumor microenvironments (TMEs) are synonymously assembled is particularly poorly characterized. Through systematic immunoprofiling of 15 commonly used mouse models, we found that most murine TMEs recapitulate the composition of poorly infiltrated human tumors, extensively biased toward high macrophage densities. We discovered substantial species-specific biases of chemokine expression networks known to drive TMEs assembly, together with discoordinated frequencies of T and myeloid cell subtypes. Even with variable alignment, conserved cell-type-specific gene expression programs emerged across species and cohorts. Dissecting the coordinated T cell\u2013myeloid gene expression programs revealed a conserved axis between interferon-responsive myeloid states and ongoing T cell cytotoxicity that transcends tissue of origin and predicts clinical outcome. Collectively, this work provides a practical atlas outlining both the hazards and opportunities of using mice to model human cancer.<\/jats:p>","DOI":"10.1038\/s41590-026-02505-7","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:03:29Z","timestamp":1779181409000},"page":"1282-1293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Differential assembly of mouse and human tumor microenvironments"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1819-9516","authenticated-orcid":false,"given":"Tristan","family":"Courau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca G.","family":"Jaszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-0897","authenticated-orcid":false,"given":"Bushra","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayvin W.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella C.","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semhar","family":"Teklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lomax F.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin W.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Wismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bunis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Lupin-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah V.","family":"Gavil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9440-3884","authenticated-orcid":false,"given":"David","family":"Masopust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-2216","authenticated-orcid":false,"given":"Daniel A.","family":"Skelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0279-5923","authenticated-orcid":false,"given":"Xavier","family":"Vesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4293-4795","authenticated-orcid":false,"given":"Edison T.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9703-2591","authenticated-orcid":false,"given":"Gabriela K.","family":"Fragiadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-6542","authenticated-orcid":false,"given":"Alexis J.","family":"Combes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7915-3533","authenticated-orcid":false,"given":"Matthew F.","family":"Krummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2505_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"2505_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni, D., Angell, H. K. & Galon, J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer 20, 662\u2013680 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2505_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830 (2018).","journal-title":"Immunity"},{"key":"2505_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev, A. et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39, 845\u2013865 (2021).","journal-title":"Cancer Cell"},{"key":"2505_CR5","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734\u20134752 (2021).","journal-title":"Cell"},{"key":"2505_CR6","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","volume":"184","author":"BA Luca","year":"2021","unstructured":"Luca, B. A. et al. Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell 184, 5482\u20135496 (2021).","journal-title":"Cell"},{"key":"2505_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2021.12.004","volume":"185","author":"AJ Combes","year":"2022","unstructured":"Combes, A. J. et al. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell 185, 184\u2013203 (2022).","journal-title":"Cell"},{"key":"2505_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.it.2021.09.007","volume":"42","author":"K Im","year":"2021","unstructured":"Im, K., Combes, A. J., Spitzer, M. H., Satpathy, A. T. & Krummel, M. F. Archetypes of checkpoint-responsive immunity. Trends Immunol. 42, 960\u2013974 (2021).","journal-title":"Trends Immunol."},{"key":"2505_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41568-023-00578-2","volume":"23","author":"AJ Combes","year":"2023","unstructured":"Combes, A. J., Samad, B. & Krummel, M. F. Defining and using immune archetypes to classify and treat cancer. Nat. Rev. Cancer 23, 491\u2013505 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"2505_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41416-019-0495-5","volume":"121","author":"CR Ireson","year":"2019","unstructured":"Ireson, C. R., Alavijeh, M. S., Palmer, A. M., Fowler, E. R. & Jones, H. J. The role of mouse tumour models in the discovery and development of anticancer drugs. Br. J. Cancer 121, 101\u2013108 (2019).","journal-title":"Br. J. Cancer"},{"key":"2505_CR11","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1073\/pnas.1222738110","volume":"110","author":"T Shay","year":"2013","unstructured":"Shay, T. et al. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc. Natl Acad. Sci. USA 110, 2946\u20132951 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2505_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867015","volume":"13","author":"ZB Bjornson-Hooper","year":"2022","unstructured":"Bjornson-Hooper, Z. B. et al. A comprehensive atlas of immunological differences between humans, mice, and non-human primates. Front. Immunol. 13, 867015 (2022).","journal-title":"Front. Immunol."},{"key":"2505_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.immuni.2022.07.008","volume":"55","author":"K Medetgul-Ernar","year":"2022","unstructured":"Medetgul-Ernar, K. & Davis, M. M. Standing on the shoulders of mice. Immunity 55, 1343\u20131353 (2022).","journal-title":"Immunity"},{"key":"2505_CR14","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","volume":"271","author":"DR Leach","year":"1996","unstructured":"Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734\u20131736 (1996).","journal-title":"Science"},{"key":"2505_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"2505_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrc.2017.92","volume":"17","author":"N Gengenbacher","year":"2017","unstructured":"Gengenbacher, N., Singhal, M. & Augustin, H. G. Preclinical mouse solid tumour models: status quo, challenges and perspectives. Nat. Rev. Cancer 17, 751\u2013765 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"2505_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s41231-019-0050-7","volume":"4","author":"AA Seyhan","year":"2019","unstructured":"Seyhan, A. A. Lost in translation: the valley of death across preclinical and clinical divide\u2014identification of problems and overcoming obstacles. Transl. Med. Commun. 4, 18 (2019).","journal-title":"Transl. Med. Commun."},{"key":"2505_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1158\/2326-6066.CIR-16-0114","volume":"5","author":"SIS Mosely","year":"2017","unstructured":"Mosely, S. I. S. et al. Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery. Cancer Immunol. Res. 5, 29\u201341 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"2505_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206223","volume":"13","author":"JW Yu","year":"2018","unstructured":"Yu, J. W. et al. Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. PLoS ONE 13, e0206223 (2018).","journal-title":"PLoS ONE"},{"key":"2505_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0794-7","volume":"7","author":"MA Taylor","year":"2019","unstructured":"Taylor, M. A. et al. Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery. J. Immunother. Cancer 7, 328 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"2505_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80216-1","volume":"11","author":"WR Gutierrez","year":"2021","unstructured":"Gutierrez, W. R. et al. Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models. Sci. Rep. 11, 1098 (2021).","journal-title":"Sci. Rep."},{"key":"2505_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1320614","volume":"14","author":"M Carretta","year":"2024","unstructured":"Carretta, M. et al. Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells. Front. Immunol. 14, 1320614 (2024).","journal-title":"Front. Immunol."},{"key":"2505_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-6344-3","volume":"21","author":"W Zhong","year":"2020","unstructured":"Zhong, W. et al. Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors. BMC Genomics 21, 2 (2020).","journal-title":"BMC Genomics"},{"key":"2505_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.stem.2023.05.001","volume":"30","author":"KH Hu","year":"2023","unstructured":"Hu, K. H. et al. Transcriptional space-time mapping identifies concerted immune and stromal cell patterns and gene programs in wound healing and cancer. Cell Stem Cell 30, 885\u2013903 (2023).","journal-title":"Cell Stem Cell"},{"key":"2505_CR25","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911\u20134927 (2003).","journal-title":"J. Virol."},{"key":"2505_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003735","volume":"9","author":"K Richter","year":"2013","unstructured":"Richter, K. et al. Macrophage and T cell produced IL-10 promotes viral chronicity. PLoS Pathog. 9, e1003735 (2013).","journal-title":"PLoS Pathog."},{"key":"2505_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2012.10.022","volume":"38","author":"BA Norris","year":"2013","unstructured":"Norris, B. A. et al. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38, 309\u2013321 (2013).","journal-title":"Immunity"},{"key":"2505_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.coi.2019.04.014","volume":"58","author":"M Philip","year":"2019","unstructured":"Philip, M. & Schietinger, A. Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections. Curr. Opin. Immunol. 58, 98\u2013103 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"2505_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"2505_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","volume":"177","author":"M Binnewies","year":"2019","unstructured":"Binnewies, M. et al. Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity. Cell 177, 556\u2013571 (2019).","journal-title":"Cell"},{"key":"2505_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten, K. et al. Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer. Cancer Cell 40, 624\u2013638 (2022).","journal-title":"Cancer Cell"},{"key":"2505_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/hep.32419","volume":"76","author":"S Suthen","year":"2022","unstructured":"Suthen, S. et al. Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC. Hepatology 76, 1329\u20131344 (2022).","journal-title":"Hepatology"},{"key":"2505_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","volume":"58","author":"J Waibl Polania","year":"2025","unstructured":"Waibl Polania, J. et al. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity 58, 232\u2013246 (2025).","journal-title":"Immunity"},{"key":"2505_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman, W. H. et al. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat. Rev. Clin. Oncol. 19, 441\u2013457 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2505_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91487","volume":"2","author":"C Gu-Trantien","year":"2017","unstructured":"Gu-Trantien, C. et al. CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight 2, e91487 (2017).","journal-title":"JCI Insight"},{"key":"2505_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez, A. B. et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep. 36, 109422 (2021).","journal-title":"Cell Rep."},{"key":"2505_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157215","volume":"7","author":"M Ukita","year":"2022","unstructured":"Ukita, M. et al. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. JCI Insight 7, e157215 (2022).","journal-title":"JCI Insight"},{"key":"2505_CR38","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.gastro.2021.09.066","volume":"162","author":"H Jiang","year":"2022","unstructured":"Jiang, H. et al. Activating immune recognition in pancreatic ductal adenocarcinoma via autophagy inhibition, MEK blockade, and CD40 agonism. Gastroenterology 162, 590\u2013603 (2022).","journal-title":"Gastroenterology"},{"key":"2505_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty, A. T. et al. LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature 611, 148\u2013154 (2022).","journal-title":"Nature"},{"key":"2505_CR40","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp, K. M. et al. Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat. Cancer 5, 1045\u20131062 (2024).","journal-title":"Nat. Cancer"},{"key":"2505_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein, J. N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"2505_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature17655","volume":"532","author":"LK Beura","year":"2016","unstructured":"Beura, L. K. et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512\u2013516 (2016).","journal-title":"Nature"},{"key":"2505_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel, T. R., Lill, J. K. & Altenburger, L. M. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer 24, 28\u201350 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"2505_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli, K., Pillarisetty, V. G. & Kim, T. S. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 29, 10\u201321 (2022).","journal-title":"Cancer Gene Ther."},{"key":"2505_CR45","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 in T cell function. Exp. Cell Res. 317, 620\u2013631 (2011).","journal-title":"Exp. Cell Res."},{"key":"2505_CR46","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","volume":"50","author":"MT Chow","year":"2019","unstructured":"Chow, M. T. et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity 50, 1498\u20131512 (2019).","journal-title":"Immunity"},{"key":"2505_CR47","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","volume":"27","author":"P Voabil","year":"2021","unstructured":"Voabil, P. et al. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nat. Med. 27, 1250\u20131261 (2021).","journal-title":"Nat. Med."},{"key":"2505_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001136","volume":"9","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. J. Immunother. Cancer 9, e001136 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2505_CR49","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell 39, 1578\u20131593 (2021).","journal-title":"Cancer Cell"},{"key":"2505_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005545","volume":"11","author":"M Sorin","year":"2023","unstructured":"Sorin, M. et al. Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity. J. Immunother. Cancer 11, e005545 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2505_CR51","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","volume":"29","author":"A Magen","year":"2023","unstructured":"Magen, A. et al. Intratumoral dendritic cell\u2013CD4+ T helper cell niches enable CD8+T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat. Med. 29, 1389\u20131399 (2023).","journal-title":"Nat. Med."},{"key":"2505_CR52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger, S., Dai, D., Horton, B. & Gajewski, T. F. Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell 31, 711\u2013723 (2017).","journal-title":"Cancer Cell"},{"key":"2505_CR53","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry, K. C. et al. A natural killer\u2013dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat. Med. 24, 1178\u20131191 (2018).","journal-title":"Nat. Med."},{"key":"2505_CR54","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","volume":"26","author":"ML Broz","year":"2014","unstructured":"Broz, M. L. et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 26, 638\u2013652 (2014).","journal-title":"Cancer Cell"},{"key":"2505_CR55","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.tig.2018.07.003","volume":"34","author":"GL Stein-O\u2019Brien","year":"2018","unstructured":"Stein-O\u2019Brien, G. L. et al. Enter the matrix: factorization uncovers knowledge from omics. Trends Genet. 34, 790\u2013805 (2018).","journal-title":"Trends Genet."},{"key":"2505_CR56","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker, G. S. et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat. Genet. 52, 1208\u20131218 (2020).","journal-title":"Nat. Genet."},{"key":"2505_CR57","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cels.2022.06.005","volume":"13","author":"LM Murrow","year":"2022","unstructured":"Murrow, L. M. et al. Mapping hormone-regulated cell\u2013cell interaction networks in the human breast at single-cell resolution. Cell Systems 13, 644\u2013664 (2022).","journal-title":"Cell Systems"},{"key":"2505_CR58","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"2505_CR59","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41586-025-08633-8","volume":"640","author":"TE Miller","year":"2025","unstructured":"Miller, T. E. et al. Programs, origins and immunomodulatory functions of myeloid cells in glioma. Nature 640, 1072\u20131082 (2025).","journal-title":"Nature"},{"key":"2505_CR60","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","volume":"167","author":"JL Benci","year":"2016","unstructured":"Benci, J. L. et al. Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade. Cell 167, 1540\u20131554 (2016).","journal-title":"Cell"},{"key":"2505_CR61","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","volume":"178","author":"JL Benci","year":"2019","unstructured":"Benci, J. L. et al. Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade. Cell 178, 933\u2013948 (2019).","journal-title":"Cell"},{"key":"2505_CR62","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.ccell.2024.10.014","volume":"42","author":"K H\u00e4nggi","year":"2024","unstructured":"H\u00e4nggi, K. et al. Interleukin-1\u03b1 release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity. Cancer Cell 42, 2015\u20132031 (2024).","journal-title":"Cancer Cell"},{"key":"2505_CR63","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.it.2025.03.001","volume":"46","author":"N Caronni","year":"2025","unstructured":"Caronni, N., La Terza, F., Frosio, L. & Ostuni, R. IL-1\u03b2+ macrophages and the control of pathogenic inflammation in cancer. Trends Immunol. 46, 403\u2013415 (2025).","journal-title":"Trends Immunol."},{"key":"2505_CR64","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210120","volume":"11","author":"L Remnant","year":"2021","unstructured":"Remnant, L., Kochanova, N. Y., Reid, C., Cisneros-Soberanis, F. & Earnshaw, W. C. The intrinsically disorderly story of Ki-67. Open Biol. 11, 210120 (2021).","journal-title":"Open Biol."},{"key":"2505_CR65","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41556-019-0298-1","volume":"21","author":"C Salvagno","year":"2019","unstructured":"Salvagno, C. et al. Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response. Nat. Cell Biol. 21, 511\u2013521 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2505_CR66","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","volume":"637","author":"A Elewaut","year":"2025","unstructured":"Elewaut, A. et al. Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature 637, 716\u2013725 (2025).","journal-title":"Nature"},{"key":"2505_CR67","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240957","volume":"222","author":"A Ray","year":"2024","unstructured":"Ray, A. et al. Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis. J. Exp. Med. 222, e20240957 (2024).","journal-title":"J. Exp. Med."},{"key":"2505_CR68","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41591-020-0892-6","volume":"26","author":"BM Allen","year":"2020","unstructured":"Allen, B. M. et al. Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Nat. Med. 26, 1125\u20131134 (2020).","journal-title":"Nat. Med."},{"key":"2505_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14811","volume":"8","author":"S Abolins","year":"2017","unstructured":"Abolins, S. et al. The comparative immunology of wild and laboratory mice, Mus musculus domesticus. Nat. Commun. 8, 14811 (2017).","journal-title":"Nat. Commun."},{"key":"2505_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw4361","volume":"365","author":"SP Rosshart","year":"2019","unstructured":"Rosshart, S. P. et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science 365, eaaw4361 (2019).","journal-title":"Science"},{"key":"2505_CR71","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463\u20131469 (2016).","journal-title":"Science"},{"key":"2505_CR72","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998\u20131013 (2018).","journal-title":"Cell"},{"key":"2505_CR73","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","volume":"41","author":"MJ Friedrich","year":"2023","unstructured":"Friedrich, M. J. et al. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell 41, 711\u2013725 (2023).","journal-title":"Cancer Cell"},{"key":"2505_CR74","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.ccell.2025.08.004","volume":"43","author":"T Courau","year":"2025","unstructured":"Courau, T., Desai, A., Wagner, A., Combes, A. J. & Krummel, M. F. The coming era of nudge drugs for cancer. Cancer Cell 43, 1973\u20131979 (2025).","journal-title":"Cancer Cell"},{"key":"2505_CR75","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.it.2021.10.007","volume":"42","author":"SE Gilbertson","year":"2021","unstructured":"Gilbertson, S. E. & Weinmann, A. S. Conservation and divergence in gene regulation between mouse and human immune cells deserves equal emphasis. Trends Immunol. 42, 1077\u20131087 (2021).","journal-title":"Trends Immunol."},{"key":"2505_CR76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41586-018-0657-2","volume":"563","author":"T Hagai","year":"2018","unstructured":"Hagai, T. et al. Gene expression variability across cells and species shapes innate immunity. Nature 563, 197\u2013202 (2018).","journal-title":"Nature"},{"key":"2505_CR77","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/erm.09.31","volume":"9","author":"P Taneja","year":"2009","unstructured":"Taneja, P. et al. MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer. Expert Rev. Mol. Diagn. 9, 423\u2013440 (2009).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"2505_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"2505_CR79","doi-asserted-by":"crossref","unstructured":"Schmidt, U., Weigert, M., Broaddus, C. & Myers, G. Cell detection with star-convex polygons. In Proc. Medical Image Computing and Computer Assisted Intervention \u2013 MICCAI 2018 (eds Frangi, A. F. et al.) 265\u2013273 (Springer, 2018).","DOI":"10.1007\/978-3-030-00934-2_30"},{"key":"2505_CR80","doi-asserted-by":"publisher","first-page":"D1305","DOI":"10.1093\/nar\/gkad1051","volume":"52","author":"JA Baron","year":"2024","unstructured":"Baron, J. A. et al. The DO-KB Knowledgebase: a 20-year journey developing the disease open science ecosystem. Nucleic Acids Res. 52, D1305\u2013D1314 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2505_CR81","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1093\/bioinformatics\/btx334","volume":"33","author":"MN Bernstein","year":"2017","unstructured":"Bernstein, M. N., Doan, A. & Dewey, C. N. MetaSRA: normalized human sample-specific metadata for the Sequence Read Archive. Bioinformatics 33, 2914\u20132923 (2017).","journal-title":"Bioinformatics"},{"key":"2505_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02533-6","volume":"22","author":"C Wilks","year":"2021","unstructured":"Wilks, C. et al. recount3: summaries and queries for large-scale RNA-seq expression and splicing. Genome Biol. 22, 323 (2021).","journal-title":"Genome Biol."},{"key":"2505_CR83","doi-asserted-by":"publisher","unstructured":"Gibbs, D. L. Robust classification of immune subtypes in cancer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.01.17.910950 (2020).","DOI":"10.1101\/2020.01.17.910950"},{"key":"2505_CR84","doi-asserted-by":"publisher","first-page":"eadt3537","DOI":"10.1126\/sciimmunol.adt3537","volume":"10","author":"A Ray","year":"2025","unstructured":"Ray, A. et al. Multimodal delineation of a layer of effector function among exhausted CD8 T cells in tumors. Sci. Immunol. 10, eadt3537 (2025).","journal-title":"Sci. Immunol."},{"key":"2505_CR85","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"J-P Brunet","year":"2004","unstructured":"Brunet, J.-P., Tamayo, P., Golub, T. R. & Mesirov, J. P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl Acad. Sci. USA 101, 4164\u20134169 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2505_CR86","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02505-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:02:11Z","timestamp":1787731331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02505-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02505-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.07.01.661217","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}